Pakistan Pharmaceutical Industry
Pakistan has a very vibrant and forward looking Pharma Industry. At the time of
independence in 1947, there was hardly any pharma industry in the country. Today
Pakistan has about 400 pharmaceutical manufacturing units including those operated
by 25 multinationals present in the country. The Pakistan Pharmaceutical Industry
meets around 70% of the country's demand of Finished Medicine. The domestic pharma market, in term
of share market is almost evenly divided between the Nationals and the Multinationals.
The National pharma industry has shown a progressive growth over the years, particularly
over the last one decade. The industry has invested substantially to upgrade itself
in the last few years and today the majority industry is following Good Manufacturing
Practices (GMP), in accordance with the domestic as well as international Guidance.
Currently the industry has the capacity to manufacture a variety of product ranging
from simple pills to sophisticated Biotech, Oncology and Value Added Generic compounds.
Although Pakistan 's pharmaceutical and healthcare sectors are expanding and evolving
rapidly, about half the population has no access to modern medicines. Clearly this
presents an opportunity, but much more work needs to be done by the government and
industry's stakeholders. The value of pharmaceuticals sold in 2007 exceeded US$1.4bn,
which equates to per capita consumption of less than US$ 10 per year and value of
medicines sold is expected to exceed US$2.3 B by 2012.
Pakistan is a developing pharmaceutical market, with a large population and economic
progress evident, but per capita drug spending was rather low at around US$9.30
in 2007. Private spending accounts for 65% of total healthcare expenditure sourced
through out-of pocket payments, international aid and religious or charitable institutions.
Pharmaceutical spending accounts for less than 1% of the country's GDP, comparable
to levels in some neighboring countries but above that in some of the South Asian
countries. The forecast period is likely to witness the marginal strengthening of
the generics sector, albeit more in terms of volumes than values. The share of generics
is also likely to increase further as major drugs come off-patent in the near term,
to the likely benefit of the generics-dominated local industry.
The Pakistan pharma industry is relatively young in the international markets with
an export turnover of over US$ 100 Million as of 2007. Pakistan Pharma Industry
boasts of quality producers and many units are approved by regulatory authorities
all over the world. Like domestic market the
sales in international market have gone almost double during last five years. The
pharma industry is focusing to an Export Vision of USD 500 Million by 2013. In the
meantime, exports are also likely to be boosted by new regional and global opportunities.
The Pakistan Pharmaceutical Industry is a success story, providing high quality
essential drugs at affordable prices to Millions. Technologically, strong and self
reliant National Pharmaceutical Industry is not only playing a key role in promoting
and sustaining development in the vital field of medicine within the country, but
is also well set to take on the international markets.